• How Sunstone Therapies is Opening Doors to Psychedelic Treatment

  • Jun 1 2024
  • Durée: 47 min
  • Podcast

How Sunstone Therapies is Opening Doors to Psychedelic Treatment

  • Résumé

  • In this episode I speak to Norma Stevens, LCPC, the Director of Therapy Operations at Sunstone Therapies in Rockville, Maryland. Sunstone partners with companies like Beckley PsyTech, COMPASS Pathways, MindMed, MAPS (Lykos Theraputics), Reunion Neuroscience, and Usona to run studies that aim to establish the gold standard for psychedelic treatments of complex mental health challenges.

    Sunstone offers research trials in a unique partnership with the Acquilino Cancer Center, a research program within Adventist HealthCare. Sunstone works with psilocybin, MDMA, 5-MeO-DMT, and LSD in conjunction with psychotherapy. We discuss the role of psychological integration after a psychedelic journey and the importance of a therapeutic set and setting.

    Voir plus Voir moins
activate_Holiday_promo_in_buybox_DT_T2

Ce que les auditeurs disent de How Sunstone Therapies is Opening Doors to Psychedelic Treatment

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.